# The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults

> **NCT03826914** · NA · COMPLETED · sponsor: **University of Manitoba** · enrollment: 69 (actual)

## Conditions studied

- Cardiovascular Diseases
- Cardiovascular Abnormalities
- Heart Attack
- Stroke
- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** CardioFlex Q10
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03826914
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-06
- **Primary completion:** 2019-06-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03826914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03826914, "The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03826914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*